Xavier Martinez (@xavierjohnm) header
Xavier Martinez (@xavierjohnm) profile picture

Reporter @WSJ covering biotech. From the "Apple Capital of the World"

Joined June 2020
Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)Photo by Xavier Martinez (@xavierjohnm)
We wrote about this disconnect between silicon valley and biopharma executives last week Drugmakers say ai can do great things in bio, even generate brand new drugs that have great potential But "cure" is a big word (see $VRTX's Jeff Leiden below)
Anthropic CEO predicts cancer, Alzheimer's, heart disease, mental illness will be cured in less than 10 years ACCELERATE
1
1
2
235
Some reasons why: - making safe/effective drugs is hard because...biology. haven't seen ai make great leaps in clinical success (so far) - ai can design drugs, but not necessarily new/innovative drugs - regulatory timelines are still long - lack of good training data
1
77
Xavier Martinez retweeted
A new type of blood thinner from @Bayer was just approved by @FDA. It is the first shown in testing to prevent repeat strokes without significantly increasing a person’s bleeding risk. Our story below: wsj.com/health/pharma/new-ty…
1
2
340
Xavier Martinez retweeted
AstraZeneca recently made a roughly $10 billion offer to buy Rhythm Pharmaceuticals, a deal that would expand its portfolio of rare disease treatments on.wsj.com/4A7zDfV
13
4
7
6,853
Exclusive w/ @laurenthomas: AstraZeneca recently made a $10 billion offer to buy Rhythm Pharmaceuticals, a Boston-based company that makes drugs for rare metabolic conditions. AstraZeneca had previously expressed interest in Rhythm. Link in thread...
1
3
4
1,122
Xavier Martinez retweeted
Dr. Annie Andrews, a pediatrician and gun-safety advocate, has defeated Republican Sen. Darline Graham for a South Carolina Senate seat, according to the Associated Press. She’s the first Democratic senator to be elected in the state since 1998. on.wsj.com/4AgLUPr
9
20
8
132
54,321
Xavier Martinez retweeted
Replying to @MHackman
@MHackman is one of the coolest people I know, and in this amazing video she takes you to her Persian Jewish community to explore the complicated politics of the ongoing war in Iran. Definitely worth watching: wsj.com/video/series/rooted-…
2
11
21
3,516
Xavier Martinez retweeted
Exclusive: A new Labor Department regulation aims to pry open the business model of PBMs, powerful companies that oversee hundreds of billions of dollars’ worth of drug spending on.wsj.com/3W8xodS
18
20
4
65
54,181
Xavier Martinez retweeted
To the scientific world, Moderna’s cancer vaccine’s results proved that a highly personalized, immune-targeting medication can work. To investors, it didn’t work well enough. W/ @xavierjohnm: wsj.com/health/pharma/modern…
2
1
5
1,756
Xavier Martinez retweeted
EXCLUSIVE - Top RFK Jr. ally and adviser Calley Means has quit the Trump administration. Means was frustrated by White House delays of some of Kennedy’s popular food policies and blamed others in the administration for allowing food companies and special interests to have too much sway, people familiar with the matter said. One of them described him as “disillusioned.” wsj.com/politics/policy/call…
61
187
35
696
213,163
Xavier Martinez retweeted
#ESMO26: The embargo on LBA1, “INTerpath-001: Phase 3 study of the mRNA-based individualised neoantigen therapy intismeran autogene plus pembrolizumab versus pembrolizumab alone for adjuvant treatment of resected stage IIB-IV melanoma”, has been breached. As the data are now publicly available, ESMO has released the information contained in the abstract and has lifted the embargo on the full dataset.
2
28
16
134
88,630